Text Size

Effect of Remote Ischemic Preconditioning on Incidence of Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Graft Surgery

This study is currently recruiting participants.
Verified December 2011 by Baystate Medical Center
Sponsor:
Information provided by (Responsible Party):
Amir Lotfi, MD, Baystate Medical Center
ClinicalTrials.gov Identifier:
NCT01500369
First received: December 22, 2011
Last updated: December 27, 2011
Last verified: December 2011
History of Changes
  Purpose

Atrial fibrillation is the most common arrhythmic complication after coronary artery bypass grafting (CABG). Post operative atrial fibrillation (POAF) increases morbidity and mortality. Inflammation could be a factor in POAF and recent evidence of remotely inducing ischemia may reduce inflammation and cardiac injury. The investigators plan to use a blood pressure cuff on the arm as a method to produce remote ischemia and assess the occurrence of POAF for seven day.


Condition Intervention Phase
Atrial Fibrillation
 Other: sphygmomanometer cuff inflations
Other: standard of care
 Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Prevention
Official Title: Effect of Remote Ischemic Preconditioning on Incidence of Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Graft Surgery A Randomized Controlled Trial

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Baystate Medical Center:

Primary Outcome Measures:
  • Post op atrial fibrillation [ Time Frame: 7 days post cardiac surgery ] [ Designated as safety issue: No ]
    Assess the indicence of post operative atrial fibrillation


Secondary Outcome Measures:
  • Stroke [ Time Frame: 7 days ] [ Designated as safety issue: Yes ]
    Post operative stroke


Estimated Enrollment: 410
Study Start Date: December 2010
Estimated Study Completion Date: June 2014
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: remote ischemic conditiong
Patients in the treatment group will receive three sequential sphygmomanometer cuff inflations on their right upper arm after induction of anesthesia in the operating room. The cuff will be inflated by the OR nurse up to 200 mmHg for five minutes each occasion, with five minutes deflation in between inflations. Following this "pre-conditioning" phase, routine anesthesia procedures will be implemented. The entire pre-conditioning phase will last 30 minutes.
 Other: sphygmomanometer cuff inflations
: Patients in the treatment group will receive three sequential sphygmomanometer cuff inflations on their right upper arm after induction of anesthesia in the operating room. The cuff will be inflated by the OR nurse up to 200 mmHg for five minutes each occasion, with five minutes deflation in between inflations. Following this "pre-conditioning" phase, routine anesthesia procedures will be implemented. The entire pre-conditioning phase will last 30 minutes.
Placebo Comparator: Standard Care
Patients in the control group will have the sphygmomanometer cuff placed on their right upper arm, but the cuff will not be inflated. Similar to patients in the treatment group, patients in the control group will undergo the same 30 minute delay before induction of anesthesia and surgery
 Other: standard of care
Placebo Comparator

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • This will be a prospective randomized controlled study on patients older than 18 years old who are undergoing elective CABG with or without valve surgery.

Exclusion Criteria:

  • any preoperative rhythm other than sinus,
  • history of atrial fibrillation,
  • New York Hear Association (NYHA) IV congestive heart failure,
  • cardiogenic shock,
  • emergent CABG and/or valve surgery,
  • bleeding diathesis, and
  • women of child-bearing potential. Eligible patients will participate after obtaining consent.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01500369

Contacts
Contact: Amir Lotfi, MD 413 7934 4490 amir.lotfi@bhs.org

Locations
United States, Massachusetts
Baystate Medical Center Recruiting
Springfield, Massachusetts, United States, 01199
Contact: Amir Lotfi, MD     413-794-4490     amir.lotfi@bhs.org    
Sponsors and Collaborators
Baystate Medical Center
Investigators
Principal Investigator: amir Lotfi, MD Baystate Medical Center
  More Information

No publications provided

Responsible Party: Amir Lotfi, MD, MD, Baystate Medical Center
ClinicalTrials.gov Identifier: NCT01500369     History of Changes
Other Study ID Numbers: Unique Protocol ID
Study First Received: December 22, 2011
Last Updated: December 27, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Baystate Medical Center:
atrial fibrillation
remote ischemic conditioning

Additional relevant MeSH terms:
Atrial Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on May 21, 2013